Citation Impact
Citing Papers
Colorectal cancer statistics, 2020
2020 Standout
Long‐term clinical outcome of Helicobacter pylori eradication for gastric mucosa‐associated lymphoid tissue lymphoma with a reference to second‐line treatment
2005
Predictive factors for regression of gastric MALT lymphoma after anti- Helicobacter pylori treatment
2001
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
Colorectal cancer statistics, 2023
2023 Standout
Spontaneous Large-Scale Lymphoid Neogenesis and Balanced Autoimmunity versus Tolerance in the Stomach of H+/K+-ATPase-Reactive TCR Transgenic Mouse
2006 StandoutNobel
Cancer treatment and survivorship statistics, 2022
2022 Standout
Cure of Helicobacter pylori Infection and Duration of Remission of Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
1997
B‐CELL LYMPHOMA OF MALT TYPE: A REVIEW WITH SPECIAL EMPHASIS ON DIAGNOSTIC AND MANAGEMENT PROBLEMS OF LOW‐GRADE GASTRIC TUMOURS
1998
Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells
2002
Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use
2002 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2008 Standout
Inflammation and cancer
2002 StandoutNature
Medicinal plants and antimicrobial activity
2005 Standout
Wearable biosensors for healthcare monitoring
2019 Standout
Gastric cancer epidemiology and risk factors
2003
Borrelia burgdorferi—associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a
1997
Gastric mucosa: long-term outcome after cure ofHelicobacter pylori infection
2002
The antibacterial mode of action of allitridi for its potential use as a therapeutic agent againstHelicobacter pylori infection
2009
Risk factors associated withHelicobacter pyloriinfection treatment failure in a high prevalence area
2010
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Which test to use to detect Helicobacter pylori infection in patients with low-grade gastric mucosa-associated lymphoid tissue lymphoma?
2003
Gastric MALT lymphoma: Epidemiology and high adenocarcinoma risk in a nation-wide study
2008
Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation
2006
Lymphoid Malignancies: the dark side of B-cell differentiation
2002
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
2014 Standout
Primary gastric B-Cell lymphoma: Results of a prospective multicenter study
2000
Clinical Epidemiological Quality in Molecular Genetic Research
1999
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori
2002
VIRULENCE GENES AND HOST AND β GENES INTERPLAY IN FAVOURING THE DEVELOPMENT OF PEPTIC ULCER AND INTESTINAL METAPLASIA
2002
Helicobacter heilmannii–associated primary gastric low-grade MALT lymphoma: Complete remission after curing the infection
2000
Antimicrobial treatment of H. pylori infection-a pooled efficacy analysis of eradication therapies
2002
Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series: Figure 1
2007
AID is required for germinal center–derived lymphomagenesis
2007 StandoutNobel
Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island
2004 Standout
Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue
2005
Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori–infected adults
1999
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Helicobacter pylori infection and gastric lymphoma
1998
Essential Oils in Food Preservation: Mode of Action, Synergies, and Interactions with Food Matrix Components
2012 Standout
Outbred mice with long-termHelicobacter felis infection develop both gastric lymphoid tissue and glandular hyperplastic lesions
2000
The primary transcriptome of the major human pathogen Helicobacter pylori
2010 StandoutNature
Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection
1998
Stool antigen assay (HpSA) is less reliable than urea breath test for post‐treatment diagnosis of Helicobacter pylori infection
2002
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Helicobacter pylori: perspectives and time trends
2014
Death and anti-death: tumour resistance to apoptosis
2002 Standout
H pylori antibiotic resistance: prevalence, importance, and advances in testing
2004 Standout
High resolution structural analysis of Helicobacter pylori VacA toxin oligomers by cryo-negative staining electron microscopy
2005 StandoutNobel
Non-Hodgkin lymphoma
2012
Helicobacter pyloriInfection
2002 Standout
Helicobacter pylori: an invading microorganism? A review
2003
Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions
2015 Standout
High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand
2015
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT
2011
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
2007 Standout
Sex and virulence in Escherichia coli: an evolutionary perspective
2006 Standout
How Do Practicing Clinicians Manage Helicobacter pylori‐Related Gastrointestinal Diseases in Germany? A Survey of Gastroenterologists and Family Practitioners
1998
Review article: the treatment of refractory Helicobacter pylori infection
2003
Guidelines for the management of Helicobacter pylori infection
1998
Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series
2003
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
Lyme borreliosis
2011 Standout
The diagnosis and treatment ofHelicobacter pyloriinfection in Arctic regions with a high prevalence of infection: Expert Commentary
2015
Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment—Helicobacter pylori positive (CADET-Hp) randomised controlled trial
2002
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia
2000
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
2010
Yersinia pestis , the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis
1999 Standout
Saliva-Based Biosensors: Noninvasive Monitoring Tool for Clinical Diagnostics
2014
23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G
2005 StandoutNobel
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
The gastric marginal zone B-cell lymphoma of MALT type
2000
Revised Response Criteria for Malignant Lymphoma
2007 Standout
A review of human carcinogens—Part B: biological agents
2009 Standout
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
The Relationship among Previous Antimicrobial Use, Antimicrobial Resistance, and Treatment Outcomes for Helicobacter pylori Infections
2003
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week—a meta‐analysis of efficacy
2000
Colorectal cancer statistics, 2017
2017 Standout
Prospective Trial in Saudi Arabia Comparing the 14-day Standard Triple Therapy with the 10-day Sequential Therapy for Treatment of Helicobacter Pylori Infection
2015
Multilocus Sequence Typing of Total-Genome-Sequenced Bacteria
2012 Standout
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Long-Term Persistence of Monoclonal B Cells After Cure of Helicobacter pylori Infection and Complete Histologic Remission in Gastric Mucosa–Associated Lymphoid Tissue B-Cell Lymphoma
2001
Evaluation of the Association of NineHelicobacter pyloriVirulence Factors with Strains Involved in Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
2004
How Do Clinicians Practicing in the U.S. Manage Helicobacter pylori-Related Gastrointestinal Diseases? A Comparison of Primary Care and Specialist Physicians
1998
Lymphoid neogenesis:de novoformation of lymphoid tissue in chronic inflammation through expression of homing chemokines
2001
Cancer treatment and survivorship statistics, 2016
2016 Standout
Racial Variations in Postoperative Outcomes of Carotid Endarterectomy
2002
Uptake ofHelicobacter pyloriOuter Membrane Vesicles by Gastric Epithelial Cells
2010
Free recombination within Helicobacter pylori
1998
A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication rates
1999
Cancer treatment and survivorship statistics, 2019
2019 Standout
Clinical Manifestations and Diagnosis of Lyme Borreliosis
2009
Epithelial attachment alters the outcome of Helicobacter pylori infection
1998
The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene,MLT, Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated Lymphoid Tissue Lymphomas
1999
Activities of Garlic Oil, Garlic Powder, and Their Diallyl Constituents against Helicobacter pylori
2000
Guidelines in the management of Helicobacter pylori infection in Japan
2003
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
The gastric marginal zone B-cell lymphoma of MALT type
2000
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
The Disease Spectrum ofHelicobacter Pylori: The Immunopathogenesis of Gastroduodenal Ulcer and Gastric Cancer
2000
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori
1996
Racial-Ethnic Disparities in Stroke Care: The American Experience
2011 Standout
Deciphering the Unusual Acylation Pattern of Helicobacter pylori Lipid A
2008
Long-Term Follow-Up of Gastric MALT Lymphoma After Helicobacter Pylori Eradication
2005
High prevalence of hepatitis C virus infection in patients with B‐cell lymphoproliferative disorders in Italy
1997
Works of M. Group being referenced
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection
1995